本页面由Tiger Trade Technology Pte. Ltd.提供服务

C4 Therapeutics, Inc.

4.01
+0.01000.25%
成交量:95.34万
成交额:370.72万
市值:4.93亿
市盈率:-4.41
高:4.03
开:3.97
低:3.81
收:4.00
52周最高:5.17
52周最低:1.69
股本:1.23亿
流通股本:9,451.50万
量比:0.64
换手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):-0.9085
每股收益(LYR):-1.2666
净资产收益率:-48.14%
总资产收益率:-19.25%
市净率:2.00
市盈率(LYR):-3.17

数据加载中...

2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/12

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/07/28

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/06/24

重要事件披露

Form 8-K - Current report
2026/06/11

重要事件披露

Form 8-K - Current report
2026/05/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/19

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

重要事件披露

Form 8-K - Current report
2026/05/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]